Back to Search Start Over

Structural Analysis of Toxin-Neutralizing, Single-Domain Antibodies that Bridge Ricin's A-B Subunit Interface.

Authors :
Rudolph MJ
Poon AY
Kavaliauskiene S
Myrann AG
Reynolds-Peterson C
Davis SA
Sandvig K
Vance DJ
Mantis NJ
Source :
Journal of molecular biology [J Mol Biol] 2021 Jul 23; Vol. 433 (15), pp. 167086. Date of Electronic Publication: 2021 Jun 03.
Publication Year :
2021

Abstract

Ricin toxin kills mammalian cells with notorious efficiency. The toxin's B subunit (RTB) is a Gal/GalNAc-specific lectin that attaches to cell surfaces and promotes retrograde transport of ricin's A subunit (RTA) to the trans Golgi network (TGN) and endoplasmic reticulum (ER). RTA is liberated from RTB in the ER and translocated into the cell cytoplasm, where it functions as a ribosome-inactivating protein. While antibodies against ricin's individual subunits have been reported, we now describe seven alpaca-derived, single-domain antibodies (V <subscript>H</subscript> Hs) that span the RTA-RTB interface, including four Tier 1 V <subscript>H</subscript> Hs with IC <subscript>50</subscript> values <1 nM. Crystal structures of each V <subscript>H</subscript> H bound to native ricin holotoxin revealed three different binding modes, based on contact with RTA's F-G loop (mode 1), RTB's subdomain 2γ (mode 2) or both (mode 3). V <subscript>H</subscript> Hs in modes 2 and 3 were highly effective at blocking ricin attachment to HeLa cells and immobilized asialofetuin, due to framework residues (FR3) that occupied the 2γ Gal/GalNAc-binding pocket and mimic ligand. The four Tier 1 V <subscript>H</subscript> Hs also interfered with intracellular functions of RTB, as they neutralized ricin in a post-attachment cytotoxicity assay (e.g., the toxin was bound to cell surfaces before antibody addition) and reduced the efficiency of toxin transport to the TGN. We conclude that the RTA-RTB interface is a target of potent toxin-neutralizing antibodies that interfere with both extracellular and intracellular events in ricin's cytotoxic pathway.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2021 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1089-8638
Volume :
433
Issue :
15
Database :
MEDLINE
Journal :
Journal of molecular biology
Publication Type :
Academic Journal
Accession number :
34089718
Full Text :
https://doi.org/10.1016/j.jmb.2021.167086